BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31034601)

  • 1. Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database.
    Nik-Ahd F; Howard LE; Eisenberg AT; Aronson WJ; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Freedland SJ
    Cancer; 2019 Aug; 125(16):2861-2867. PubMed ID: 31034601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database.
    Moreira DM; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Boffetta P; Freedland SJ
    Cancer; 2014 Jan; 120(2):197-204. PubMed ID: 24127391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
    Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
    Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does race predict the development of metastases in men who receive androgen-deprivation therapy for a biochemical recurrence after radical prostatectomy?
    Vidal AC; Howard LE; De Hoedt A; Kane CJ; Terris MK; Aronson WJ; Cooperberg MR; Amling CL; Lechpammer S; Flanders SC; Freedland SJ
    Cancer; 2019 Feb; 125(3):434-441. PubMed ID: 30427535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy.
    Kelkar S; Oyekunle T; Eisenberg A; Howard L; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Klaassen Z; Terris MK; Freedland SJ; Csizmadi I
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34169227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, race, and long-term prostate cancer outcomes.
    Vidal AC; Oyekunle T; Howard LE; De Hoedt AM; Kane CJ; Terris MK; Cooperberg MR; Amling CL; Klaassen Z; Freedland SJ; Aronson WJ
    Cancer; 2020 Aug; 126(16):3733-3741. PubMed ID: 32497282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort.
    Mithal P; Howard LE; Aronson WJ; Terris MK; Cooperberg MR; Kane CJ; Amling C; Freedland SJ
    BJU Int; 2016 Feb; 117(2):244-8. PubMed ID: 26010160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort study.
    Barlow SK; Oyekunle T; Janes JL; De Hoedt AM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Klaassen ZW; Terris MK; Freedland SJ; Csizmadi I
    Prostate; 2022 Feb; 82(3):366-372. PubMed ID: 34905632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and Prostate Cancer Outcomes in Men with Nonmetastatic Castration-Resistant Prostate Cancer: Results from the SEARCH Cohort.
    Sergeyev A; Gu L; De Hoedt AM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Klaassen Z; Terris MK; Guerrios-Rivera L; Freedland SJ; Csizmadi I
    Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1208-1216. PubMed ID: 37294698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database.
    Yirga A; Oyekunle T; Howard LE; De Hoedt AM; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Taioli E; Fowke JH; Klaanssen Z; Freedland SJ; Vidal AC
    Cancer Causes Control; 2021 Feb; 32(2):189-197. PubMed ID: 33392907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
    Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
    BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database.
    Allott EH; Abern MR; Gerber L; Keto CJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Moorman PG; Freedland SJ
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):391-7. PubMed ID: 24100644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy.
    Kodama H; Koie T; Oikawa M; Narita T; Tanaka T; Noro D; Iwamura H; Tobisawa Y; Yoneyama T; Hashimoto Y; Ohyama C
    Int Urol Nephrol; 2020 Apr; 52(4):671-679. PubMed ID: 31897875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancer.
    Howard LE; Moreira DM; De Hoedt A; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Freedland SJ
    BJU Int; 2017 Nov; 120(5B):E80-E86. PubMed ID: 28371163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Hispanic Puerto Rican men have worse outcomes after radical prostatectomy? Results from SEARCH.
    Guerrios-Rivera L; Janes JL; De Hoedt AM; Klaassen Z; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ; Fowke JH; Freedland SJ
    Cancer Med; 2024 Feb; 13(4):e7012. PubMed ID: 38457188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic status, race, and long-term outcomes after radical prostatectomy in an equal access health system: Results from the SEARCH database.
    Everist MM; Howard LE; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Freedland SJ
    Urol Oncol; 2019 Apr; 37(4):289.e11-289.e17. PubMed ID: 30598238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Tablazon IL; Howard LE; De Hoedt AM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Freedland SJ; Williams SB
    Cancer; 2019 Nov; 125(22):4003-4010. PubMed ID: 31390061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do Hispanic Men Have Worse Outcomes After Radical Prostatectomy? Results From SEARCH.
    Guerrios-Rivera L; Howard LE; Klaassen Z; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ; Freedland SJ
    Urology; 2021 Mar; 149():181-186. PubMed ID: 33189734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies?
    Marra G; Calleris G; Alessio P; Oderda M; Palou J; Joniau S; Piechaud T; Smelzo S; Morlacco A; Sharma V; Tilki D; Van der Poel H; Veerman H; Karnes RJ; Gontero P
    Eur Urol Focus; 2021 Jul; 7(4):807-811. PubMed ID: 32414618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.